Articles From: 2014/12/8 - Celanese Welcomes Customers in Turkey to - Retail sales data to confirm tone of holiday shopping


2014/12/8
Celanese Corporation (NYSE: CE), a global technology and specialty materials company, today announced the opening of a new sales center in Istanbul, Turkey, to support customer growth of the company’s intermediate chemistry, engineered materials and emulsion polymers portfolio in Turkey and the greater European region.
Sign-up for 2014/12/8 - Celanese Welcomes Customers in Turkey investment picks
Germania Insurance, a Texas Property/Casualty (P/C) insurer, and Guidewire Software, Inc. (NYSE:GWRE), a provider of software products to P/C insurers, today announced that Germania Insurance has selected Guidewire InsuranceSuite™ as its new platform for the management of underwriting, policy administration, claims, billing, rating, client data, and reinsurance.
Sign-up for - Germania Insurance Selects Guidewire Products for Underwriting, Policy Administration, Claims Management, Data Management, Business Intelligence, and Billing investment picks
LOUISVILLE, Colo., Dec.
Sign-up for - RGS Energy Divests The Real Goods Store to Focus on Residential Solar investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0982787001&sourceType=1 http://media3.marketwire.com/logos/20140630-diffcaplogo1.jpg TORONTO, ONTARIO --
Sign-up for - Difference Capital Announces Normal Course Issuer Bid for Common Shares and Convertible Debentures investment picks
The Hershey Company (NYSE:HSY) was recognized today as one of America’s most community-minded companies in The Civic 50, an annual recognition for companies that are committed to making a difference in the communities where they do business.
Sign-up for - Hershey Once Again Named One of Top 50 Most Civically Minded U.S. Companies investment picks
Andrews & Springer LLC , a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Oiltanking Partners, L.P. (NYSE:OILT) (“Oiltanking” or the “Company”) relating to the sale of the Company to Enterprise Products Partners L.P. (“Enterprise”). On November 12, 2014, the two companies announced the signing of a definitive merger agreement pursuant to which Enterprise will acquire Oiltanking in a merger in a deal worth $1.4 billion.
Sign-up for - OILTANKING PARTNERS (OILT) INVESTIGATION - Andrews & Springer LLC Is Seeking More Cash for Unitholders of Oiltanking Partners, L.P. investment picks
Weingarten Realty Investors (NYSE:WRI) announced today that its fourth quarter 2014 earnings will be released before the market opens Tuesday, February 17, 2015.
Sign-up for - Weingarten Realty Investors Announces Fourth Quarter 2014 Earnings Release and Conference Call Dates - CORRECTED investment picks
http://media.marketwire.com/attachments/201210/90690_Cisco_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1161523&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for - REMINDER: Deutsche Bank and Cisco to Host a Conference Call on Application Centric Infrastructure investment picks
FORT WORTH, Texas , Dec.
Sign-up for - American Airlines Group Reports November Traffic Results investment picks
http://media.marketwire.com/attachments/201204/39376_FireEye_logo_RGB.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163523&ProfileId=051205&sourceType=1 MILPITAS, CA --
Sign-up for - FireEye Wins CRN Enterprise App Award for Security investment picks
Equity Commonwealth (NYSE:EQC) announced it repaid $100 million on its unsecured term loan.
Sign-up for - Equity Commonwealth Repays $100 Million on Term Loan investment picks
2014/12/8
By Ciara Linnane, MarketWatch Complexity of Affordable Care Act expected to benefit company Tax services company H&R Block Inc. is scheduled to report fiscal second-quarter earnings after the bell on Monday.
Sign-up for 2014/12/8 - UPDATE: What to look for in H&R Block earnings investment picks
ICF International (NASDAQ:ICFI), a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new contract to support an innovative energy efficiency program for a major U.S. utility.
Sign-up for - ICF International Awarded $6 Million Energy Efficiency Contract with Major U.S. Southern Utility investment picks
http://media.marketwire.com/attachments/201305/153545_PRLibertyLogo2c.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163489&ProfileId=051205&sourceType=1 VIRGINIA BEACH, VA --
Sign-up for - Liberty Tax Service Reports Fiscal 2015 Second Quarter Results investment picks
2014/12/8
Allot's Anti-DDoS and spam control capabilities helps service providers protect their data networks HOD HASHARON, Israel , December 8, 2014 /PRNewswire/ -- Allot Communications Ltd.
Sign-up for 2014/12/8 - Allot ServiceProtector Selected by Five Tier-1 Operators to Secure High Capacity Networks from Evolving Cyber Security Threats investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163515&ProfileId=051205&sourceType=1 SINGAPORE --
Sign-up for - Phorm Corporation Limited Announces Equity Fundraising investment picks
Durable Responses Observed with Patients on Study for up to Eight Months and Ongoing in Advanced Acute Myeloid Leukemia and Other Blood Cancers SAN FRANCISCO, Dec.
Sign-up for - Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies investment picks
Alnylam Pharmaceuticals , Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase 1/2 clinical trial with ALN-CC5, a subcutaneously administered investigational RNAi therapeutic targeting complement component C5 for the treatment of complement-mediated diseases.
Sign-up for - Alnylam Files Clinical Trial Application (CTA) for ALN-CC5, an RNAi Therapeutic Targeting Complement C5 in Development for the Treatment of Complement-Mediated Diseases investment picks
2014/12/7
By Juro OsawaMobile payments account for 54 out of every 100 payments HONG KONG-- Alibaba Group Holding Ltd.
Sign-up for 2014/12/7 - Alibaba: Alipay processing more transactions via mobile investment picks
Iron Ore 58% Fe, Low Alumina, CFR China (TSI) Futures to Launch December 8 NEW YORK and SINGAPORE, Dec.
Sign-up for - TSI Iron Ore Fines Index to Form Basis of New CME Futures Contract investment picks
-Only Rentrak Provides the Official Global Movie Results- LOS ANGELES , Dec.
Sign-up for - Rentrak Announces Official Worldwide Box Office Results for Weekend of December 7, 2014 investment picks
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trade in Monday's session are Vail Resorts Inc., H&R Block Inc., and Pep Boys.
Sign-up for - UPDATE: Vail Resorts, H&R Block earnings in focus investment picks
- AbbVie Presents for the First Time Results from the Venetoclax Phase 2 Program in Acute Myelogenous Leukemia - Study Evaluated Preliminary Efficacy of Venetoclax in 32 Patients with Relapsed/Refractory Acute Myelogenous Leukemia and as Frontline Therapy in Patients Unfit for Intensive Treatment NORTH CHICAGO, Ill.
Sign-up for - AbbVie Presents Results from Phase 2 Study of Investigational Compound Venetoclax (ABT-199/GDC-0199) in Acute Myelogenous Leukemia at the 56th American Society of Hematology Annual Meeting investment picks
Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced four-year overall survival (OS) data from the ADCETRIS (brentuximab vedotin) pivotal Phase 2 clinical trial in relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, which is expressed in classical Hodgkin lymphoma (HL) and systemic ALCL, a type of T-cell lymphoma.
Sign-up for - Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting investment picks
http://media.marketwire.com/attachments/201412/294981_2395-2013_Zebra_Tag_Horizontal.jpg.jpeg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163308&ProfileId=051205&sourceType=1 SINGAPORE --
Sign-up for - Zebra Technologies Strengthens Leadership Across APAC investment picks
NEWTOWN, Pa., Dec.
Sign-up for - Onconova Announces ONTIME Data Presentations at the 2014 ASH Annual Meeting investment picks
SOUTH SAN FRANCISCO, Calif., Dec.
Sign-up for - Sunesis Pharmaceuticals Announces Presentation of Results From Phase 3 VALOR Trial at ASH Annual Meeting investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- [TK - to be prepubbed on Friday for Sunday morning - lede may have to be rewritten to account for Friday developments, please update for Friday closing prices] With gas prices at multiyear lows and consumer sentiment at multiyear highs, retail sales data will likely be the main catalyst for stocks this week.
Sign-up for - Retail sales data to confirm tone of holiday shopping investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: 2014/12/8 - Celanese Welcomes Customers in Turkey to - Retail sales data to confirm tone of holiday shopping
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent